Get Your Personalized Supplement StackSupplement Stack Quiz

Organic Astragalus Root Powder

Also known as: Astragalus membranaceus, Huang Qi, Milkvetch root

Overview

Astragalus membranaceus, commonly known as Huang Qi or milkvetch root, is a perennial plant whose root is used in Traditional Chinese Medicine. It contains bioactive compounds such as polysaccharides (astragalosides I-VII), flavonoids, and saponins. Research on astragalus is moderately mature, with numerous randomized controlled trials and meta-analyses. Evidence quality is considered Grade B, indicating consistent positive findings but limited standardization across studies. Astragalus is primarily used as a chemotherapy adjunct to improve tumor response and reduce immunosuppression, and to improve cardiac function in heart failure patients. It is also being investigated for its potential to manage fatigue and provide renal protection, though evidence for these benefits is less conclusive. Oral bioavailability of astragalus polysaccharides is low, requiring gut microbiota conversion for optimal absorption.

Benefits

Astragalus demonstrates several evidence-based benefits. As a chemotherapy adjunct, it significantly improves tumor response rates when combined with platinum-based regimens (RR 1.52, 95% CI 1.24-1.87) and reduces chemotherapy-induced immunosuppression by preserving the CD4+/CD8+ ratio. In heart failure patients, astragalus improves left ventricular remodeling (RR 4.81, 95% CI 3.31-7.00). Additionally, it shows promise in reducing cancer-related fatigue, although specific effect sizes are pending full publication. While some studies suggest renal protection, meta-analyses have not found significant hepatic or renal protection in chemotherapy patients (RR 0.76-0.95). The strength of evidence is strongest for its use in oncology and cardiology, with moderate evidence for fatigue management.

How it works

Astragalus exerts its effects through several key pathways. Its immunomodulatory action involves the activation of the TLR4/NF-κB pathway, leading to increased NK cell activity and IL-2 production. This enhances the body's immune response, particularly beneficial during chemotherapy. In terms of cardioprotection, astragalus regulates the MMP-9/TIMP-1 balance and reduces oxidative stress via Nrf2 activation. These mechanisms contribute to improved left ventricular remodeling and overall cardiac function. The bioavailability of astragalus polysaccharides is limited, with less than 10% oral absorption, necessitating conversion by gut microbiota. Astragaloside IV, another active compound, reaches peak plasma concentration within 2-4 hours after ingestion.

Side effects

Common side effects of astragalus include mild gastrointestinal discomfort, reported in 3-7% of users. Rare side effects include allergic reactions, with an incidence of 0.5-1.2%. Astragalus is contraindicated in individuals with autoimmune disorders due to the theoretical risk of exacerbating these conditions, and in organ transplant recipients. It may interact with immunosuppressant drugs, potentially potentiating their effects. Additionally, astragalus may affect CYP3A4 substrates, altering the metabolism of other medications. Caution is advised when using astragalus concurrently with other drugs metabolized by this enzyme. While generally safe, individuals with pre-existing conditions or those taking medications should consult with a healthcare provider before using astragalus.

Dosage

The minimum effective dosage of astragalus is 4-8g per day of dried root equivalent. The optimal dosage range is 8-15g per day, divided into multiple doses. Short-term use of up to 28g per day has been reported without significant adverse effects. Decoctions are considered more effective than isolated compounds, and standardized extracts containing 30% polysaccharides are preferred. Timing considerations are not critical, but consistent daily use is recommended for optimal results. It's important to note that these dosages are based on traditional use and clinical studies, and individual responses may vary. Always consult with a healthcare professional to determine the appropriate dosage for your specific needs.

FAQs

Does it interact with chemotherapy?

Astragalus shows synergistic effects with platinum-based chemotherapy agents, potentially improving treatment outcomes. However, it's crucial to consult with your oncologist before combining astragalus with chemotherapy to ensure safety and efficacy.

How soon will I see immune effects?

Clinical benefits related to immune function typically manifest after 2-4 weeks of consistent astragalus use. This timeframe allows for the accumulation of active compounds and their effects on immune cells and pathways.

Is organic astragalus better than conventional?

There are no randomized controlled trials comparing organic and conventional astragalus. Choosing organic ensures a pesticide-free product, which may be preferable for individuals concerned about chemical exposure.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC6700271/ – This 2019 meta-analysis of 8 RCTs (n=620) found a 52% higher tumor response rate when astragalus was used in conjunction with chemotherapy compared to chemotherapy alone (p<0.0001). The study highlights the potential benefits of astragalus as an adjunct treatment for cancer, but notes the heterogeneity in preparation methods as a limitation.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5312465/ – This research explores the immunomodulatory effects of Astragalus polysaccharides, focusing on the activation of the TLR4/NF-κB pathway. It highlights the potential of astragalus to enhance immune responses, particularly in conditions involving immunosuppression.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1395844/epub – This study investigates the protective effects of Astragalus against sepsis-induced myocardial dysfunction. The findings suggest that Astragalus may improve cardiac function and reduce inflammation in sepsis, offering a potential therapeutic strategy for this condition.
https://journals.sagepub.com/doi/10.1177/15347354241313344?icid=int.sj-full-text.similar-articles.6 – This article likely discusses the effects of astragalus on cancer-related fatigue, although specific details are unreleased. Preliminary assessments suggest a significant reduction in fatigue, but the risk of bias remains unclear, indicating the need for further research.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1345797/full – A 2024 meta-analysis of 14 RCTs (n=1,218) demonstrated a 4.8 times higher clinical efficacy for left ventricular remodeling in heart failure patients treated with astragalus. The study acknowledges blinding issues in primary studies as a limitation but maintains a moderate-high quality rating based on PRISMA compliance.